These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18363247)

  • 1. Are heparins anti-neoplastic agents?
    Douketis JD; Lloyd NS
    Pol Arch Med Wewn; 2007; 117(11-12):491-3. PubMed ID: 18363247
    [No Abstract]   [Full Text] [Related]  

  • 2. Antimetastatic activities of heparins and modified heparins. Experimental evidence.
    Borsig L
    Thromb Res; 2010 Apr; 125 Suppl 2():S66-71. PubMed ID: 20434009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of anticoagulants on cancer: heparins.
    Pineo GF; Hull RD
    Cancer Treat Res; 2009; 148():259-75. PubMed ID: 19377929
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental and clinical effects of anticoagulants on cancer progression.
    Van Noorden CJ; van Sluis GL; Spek CA
    Thromb Res; 2010 Apr; 125 Suppl 2():S77-9. PubMed ID: 20434011
    [No Abstract]   [Full Text] [Related]  

  • 5. Heparin in tumor progression and metastatic dissemination.
    Falanga A; Marchetti M
    Semin Thromb Hemost; 2007 Oct; 33(7):688-94. PubMed ID: 18000796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor and antimetastatic effect of warfarin and heparins.
    Bobek V; Kovarík J
    Biomed Pharmacother; 2004 May; 58(4):213-9. PubMed ID: 15183845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Anticoagulant and Nonanticoagulant Properties of Heparin.
    Beurskens DMH; Huckriede JP; Schrijver R; Hemker HC; Reutelingsperger CP; Nicolaes GAF
    Thromb Haemost; 2020 Oct; 120(10):1371-1383. PubMed ID: 32820487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin and cancer.
    Zacharski LR; Ornstein DL
    Thromb Haemost; 1998 Jul; 80(1):10-23. PubMed ID: 9684778
    [No Abstract]   [Full Text] [Related]  

  • 9. Do heparins do more than just treat thrombosis? The influence of heparins on cancer spread.
    Hettiarachchi RJ; Smorenburg SM; Ginsberg J; Levine M; Prins MH; Büller HR
    Thromb Haemost; 1999 Aug; 82(2):947-52. PubMed ID: 10605808
    [No Abstract]   [Full Text] [Related]  

  • 10. The roles of anticoagulants in patients with cancer.
    Lee AY
    Thromb Res; 2010 Apr; 125 Suppl 2():S8-11. PubMed ID: 20434012
    [No Abstract]   [Full Text] [Related]  

  • 11. Non-anti-coagulant heparins: a promising approach for prevention of tumor metastasis (review).
    Kragh M; Loechel F
    Int J Oncol; 2005 Oct; 27(4):1159-67. PubMed ID: 16142335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of heparin anticoagulants to ultra-low-molecular-weight heparins: a review of pharmacologic and clinical differences and applications in patients with cancer.
    Walenga JM; Lyman GH
    Crit Rev Oncol Hematol; 2013 Oct; 88(1):1-18. PubMed ID: 23849978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The use of anticoagulants in the chemotherapy of cancer].
    Grekh IF; Shats VIa
    Vopr Onkol; 1969; 15(1):111-6. PubMed ID: 4891306
    [No Abstract]   [Full Text] [Related]  

  • 14. Determining the anti-coagulant-independent anti-cancer effects of heparin.
    Solari V; Jesudason EC; Turnbull JE; Yates EA
    Br J Cancer; 2010 Aug; 103(4):593-4. PubMed ID: 20648011
    [No Abstract]   [Full Text] [Related]  

  • 15. [Heparins, antivitamins K. Principles and rules of use. Posology of non-fractionated heparins].
    Delsart D; Chambefort V; Decousus H
    Rev Prat; 2001 Sep; 51(13):1489-97. PubMed ID: 11601082
    [No Abstract]   [Full Text] [Related]  

  • 16. Heparins in ulcerative colitis: proposed mechanisms of action and potential reasons for inconsistent clinical outcomes.
    Lean QY; Gueven N; Eri RD; Bhatia R; Sohal SS; Stewart N; Peterson GM; Patel RP
    Expert Rev Clin Pharmacol; 2015; 8(6):795-811. PubMed ID: 26308504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-molecular-weight heparins and cancer: focus on antitumoral effect.
    Franchini M; Mannucci PM
    Ann Med; 2015 Mar; 47(2):116-21. PubMed ID: 25766973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New medical anticoagulants].
    Choussat R; Montalescot G
    Rev Mal Respir; 1999 Nov; 16(5 Pt 2):985-95. PubMed ID: 10907447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low molecular weight heparins could be important in cancer.
    Siragusa S
    BMJ; 1999 Sep; 319(7213):851. PubMed ID: 10496841
    [No Abstract]   [Full Text] [Related]  

  • 20. The ability of different forms of heparins to suppress P-selectin function in vitro correlates to their inhibitory capacity on bloodborne metastasis in vivo.
    Ludwig RJ; Alban S; Bistrian R; Boehncke WH; Kaufmann R; Henschler R; Gille J
    Thromb Haemost; 2006 Mar; 95(3):535-40. PubMed ID: 16525583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.